Selenium-Fortified Mushrooms - Candidates for Nutraceuticals?

Review Article

Austin Therapeutics. 2014;1(2): 4.

Selenium-Fortified Mushrooms - Candidates for Nutraceuticals?

Witkowska AM*

Department of Food Commodities Science and Technology, Medical University of Bialystok, Poland

*Corresponding author: Witkowska AM, Department of Food Commodities Science and Technology, Medical University of Bialystok, ul. Szpitalna 37, 15-295 Bialystok, Poland

Received: August 04, 2014; Accepted: November 07, 2014; Published: November 11, 2014

Abstract

Nutraceuticals represent products developed from food sources, which offer health benefits including the prevention and treatment of chronic diseases. Cultivated mushroom fruit bodies or mycelia allow to derive various forms of products which can be used in medicinal preparations or as nutraceuticals. In recent years fungi attracted much attention due to their selenium-accumulating potential and facility to be utilized as Se-fortified food. They can absorb inorganic selenium from the substrate and convert it to organic selenium compounds, which are less toxic and better bioavailable in humans than the inorganic selenium salts. Cultivated mushrooms are usually poor in selenium, while these grown on substrates enriched in selenium may incorporate even up to 1300 μg Se/g dw under experimental conditions. Particularly good selenium accumulators among others are Agaricus bisporus, Lentinula edodes, Pleurotus ostreatus. Considering the recommended daily selenium intake of 55 μg Se/d, the consumption of high selenium mushrooms should be limited to very small amounts. In view of the data regarding adverse effects observed in clinical trials during selenium supplementation, preferably selenium inadequate populations may benefit from selenized fungi and mushroom products.

Keywords: Selenium; Mushrooms; Nutraceuticals

Abbreviations

GPx: Glutathione Peroxidase; HDL: High Density Lipoprotein; IDD: Iodothyronine Deiodinases; LDL: Low Density Lipoprotein; PCa: Prostate Cancer; RDA: Recommended Dietary Allowance; TrxR: Thioredoxin Reductase.

Introduction

The term ‘nutraceutical’ is a combination of two words: ‘nutrition’ and ‘pharmaceutical’. This means that nutraceuticals represent products developed from food sources, which offer health benefits including the prevention and treatment of chronic diseases [1]. Nutraceuticals are marketed mostly in medicinal forms as pure nutrients (vitamins, minerals), herbal products, food ingredients or food. Cultivated mushroom fruit bodies or mycelia allow deriving various forms of products which can be used in medicinal preparations or as Nutraceuticals. These forms include fresh or pulverized dried mushrooms, mycelial biomass, extracts of mycelium or culture broth.

Controversies over selenium supplementation

Selenium is an essential element for humans and animals. It exerts its physiological effects through a number of metabolic pathways, which in humans involve 25 selenoproteins [2]. Glutathione Peroxidases (GPx), Thioredoxin Reductase (TrxR) and Iodothyronine Deiodinases (IDD) are the main antioxidant selenoproteins. Severe selenium deficiency has been connected to congestive cardiomyopathy (Keshan disease) [3] and chronic endemic osteochondropathy (Kashin-Beck disease) [4]. Recently, increased incidence of colorectal cancer has been attributed to low selenium status in European populations [5]. Dietary recommendations for selenium intake vary between countries, yet the US and EU recommendations are consistent. The US Institute of Medicine, Food and Nutrition Board and the European Scientific Committee on Food of the European Commission recommend 55 μg Se/d [6,7]. This value was derived from Chinese studies, which demonstrated that a 52 μg/d selenium dose was able to maximize plasma Glutathione Peroxidase (GPx). According to experts the Recommended Dietary Allowance (RDA) for selenium should not be exceeded, because it may be deleterious for human health. In the US population high serum selenium concentrations were associated with increased total and LDL-cholesterol, while increased HDL-cholestrol was found only at low selenium level, up to 120 ng/ml [8]. Serum selenium levels in excess of 130 ng/ml may possibly be associated with increased overall mortality [9]. What is more, results of clinical trials suggest adverse effects of selenium supplementation on incidence of cardiovascular disease, diabetes and cancer. The Selenium and Vitamin E Cancer Prevention Trial (SELECT) showed no preventive effect of 200 μg/d selenoamino acid l-selenomethionine alone or in combination with vitamin E on the incidence of prostate cancer (PCa) [10]. But another report which used toenail clippings of SELECT volunteers as a measure of long-term selenium status established that selenium supplementation had no effect in men with low selenium status, but raised the risk of high-grade PCa in those with high baseline selenium status [11]. The conclusions drawn from this latter survey emphasize unfavorable effects of selenium supplementation in men at doses exceeding recommended daily intakes. With respect to primary prevention of cardiovascular disease and type 2 diabetes, a longterm supplementation with high-selenium baker’s yeast providing 200 μg Se/d was unsuccessful to demonstrate any beneficial effect [12,13]. It was also suggested that selenium supplementation may increase incidence of diabetes in selenium-adequate population (adequacy established by the author on the basis of serum selenium concentration). Animal studies have thrown light on the mechanisms behind selenium supplementation and diabetes. In these studies high intakes of selenium caused depletion in chromium levels and contributed to lipolysis in adipose tissue, which caused an influx of fatty acids in the rat liver [14]. These processes initiated metabolic reactions leading to increased mitochondrial Reactive Oxidative Species (ROS) generation and as a result weakened insulin signaling. Recently, the excess dietary selenium and increased mushroom consumption were suggested to be independent factors associated with an elevation in blood glucose, while high intakes of both were linked to increased risk of diabetes [15]. These findings raise concerns about advising on selenized mushrooms consumption or taking supplements of selenium-enriched fungi in the populations which are selenium-adequate. Selenium is present in soil, water and food sources. Some geographical regions, however, are selenium-deficient, including certain parts of Europe, New Zealand, some areas of China, what translates into reduced selenium in food. In these terms use of selenium-containing products may possibly be an option for selenium-depleted populations to improve selenium status.

Selenium-accumulating potential of mushrooms

For a long time mushrooms were considered valuable sources of nutrients, especially protein, some vitamins and minerals. They are low-fat what can be a major advantage in terms of formulation of dietary supplements. Similarly to yeast, mushrooms can absorb inorganic selenium from the substrate and convert it to organic selenium compounds, which are less toxic and better bioavailable in humans than the inorganic selenium salts [8,16,17]. Yeast has been widely cultivated for nutraceutical purposes. In recent years, however, fungi attracted more attention due to their seleniumaccumulating potential and facility to be utilized as Se-fortified food. Fungi can absorb selenium with different accumulating efficiencies. Wild-growing edible mushrooms from unpolluted areas have a potential to accumulate from <0.5 to >20 μg Se/g, and members of Boletaceae family are particularly remarkable Se-accumulators [18]. Cultivated mushrooms are usually poor in selenium (from 0.01 to about 4 μg Se/g dw) [19-21], while these grown on substrates enriched in selenium may incorporate even up to 1300 μg Se/g dw under experimental conditions [22] (Table 1). Particularly good selenium accumulators among others are Agaricus bisporus, Lentinula edodes, Pleurotus ostreatus. By contrast, fruit bodies of Ganoderma lucidum have a low, ˜30% potential to incorporate Se from a substrate [23]. Accumulation of selenium from selenized substrates is dosedependent [24]. Depending on a dose, selenium added to a substrate stimulates growth of mushrooms or mycelia. High doses of selenium, however, may be toxic to mushrooms and have the opposite effect. Da Silva et al. [25] established that selenium added to culture media of Pleurotus ostreatus and P. eryngii caused macro- and microscopic changes in mushrooms’ morphology, mainly diminished fungal growth rate, diameter of hyphae and distance of septum, and it also modified the color of colony. Malinowska et al. [26] demonstrated that low concentration of sodium selenite in growth media at a dose of 25 mg/L had no influence on white-rot fungus Hericium erinaceum, while higher doses caused a significant decrease in mycelial growth. In oyster mushroom P. ostreatus high selenium dosage at concentrations above 12.8 mg/kg substrate was found not only to reduce mycelial growth, but it also influenced mushroom’s shape (larger stipes and smaller caps) and selenium concentrations [24]. In contrast, A. bisporus can be cultivated at high selenium concentrations (approx. 1.26 M sodium selenite) not showing negative effects in mushroom quality and crop yield [27].

Citation: Witkowska AM. Selenium-Fortified Mushrooms - Candidates for Nutraceuticals?. Austin Thrapeutics. 2014;1(2): 4. ISSN:2472-3673